References
- BegleyDJDelivery of therapeutic agents to the central nervous system: the problems and the possibilitiesPharmacol Ther20041041294515500907
- KusuharaHSugiyamaYEfflux transport systems for drugs at the blood–brain barrier and blood-cerebrospinal fluid barrier (Part 1)Drug Discov Today20016315015611165188
- BatrakovaEVKabanovAVPluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiersJ Control Release200813029810618534704
- OlivierJCDrug transport to brain with targeted nanoparticlesNeuroRx20052110811915717062
- GrefRCouvreurPBarrattGSurface-engineered nanoparticles for multiple ligand couplingBiomaterials200324244529453712922162
- CalvoPRemunan-LopezCVila-JatoJLDevelopment of positively charged colloidal drug carriers: chitosan-coated polyester nanocapsules and submicron-emulsionsColloid Polym Sci199727514653
- CouvreurPVauthierCPolyalkylcyanoacrylate nanoparticles as drug carrier: present state and perspectivesJ Control Release1991172187198
- GulyaevAEGelperinaSESkidanINSignificant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticlesPharm Res199916101564156910554098
- SteinigerSCJKreuterJKhalanskyASChemotherapy of glioblastoma in rats using doxorubicin loaded nanoparticlesInt J Cancer2004109575976714999786
- TosiGCostantinoLRivasiFTargeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123J Control Release200712211917651855
- AlyautdinRGothierDPetrovVAnalgesic activity of the hexapeptide dalargin adsorbed on the surface of polysorbate 80-coated poly (butyl cyanoacrylate) nanoparticlesEur J Pharm Biopharm19954114448
- KreuterJAlyautdinRNKharkevichDAPassage of peptides through the blood–brain barrier with colloidal polymer particles (nanoparticles)Brain Res199567411711747773690
- KusuharaHSuzukiHSugiyamaYThe role of P Glycoprotein and canalicular multispecific organic anion transporter in the hepatobiliary excretion of drugsJ Pharm Sci1998879102510409724551
- LoeDWDeeleyRGColeSPBiology of the multidrug resistance-associated protein, MRPEur J Cancer19963269458763335
- HipfnerDRDeeleyRGColeSPCStructural, mechanistic and clinical aspects of MRP1Biochim Biophys Acta19991461235937610581367
- ParkJHSaravanakumarGKimKTargeted delivery of low molecular drugs using chitosan and its derivativesAdv Drug Deliver Rev20106212841
- MistryAStolnikSIllumLNanoparticles for direct nose-to-brain delivery of drugsInt J Pharm2009379114615719555750
- HuFQZhaoMDYuanHA novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studiesInt J Pharm20063151–215816616632285
- HuFQLiuLNDuYZSynthesis and antitumor activity of doxorubicin conjugated stearic acid-g-chitosan oligosaccharide polymeric micellesBiomaterials200930366955696319782395
- HuFQWuXDuYZCellular uptake and cytotoxicity of shell crosslinked stearic acid-grafted chitosan oligosaccharide micelles encapsulating doxorubicinEur J Pharm Biopharm200869111712517997293
- HuFQRenGFYuanHShell cross-linked stearic acid grafted chitosan oligosaccharide self-aggregated micelles for controlled release of paclitaxelColloids Surf B Biointerfaces20065029710316759840
- YuanHLuLDuYZStearic acid-g-chitosan polymeric micelle for oral drug delivery: in vitro transport and in vivo absorptionMol Pharm20118122523821138243
- HuangMMaZKhorEUptake of FITC-chitosan nanoparticles by A549 cellsPharm Res200219101488149412425466
- KohoriFYokoyamaMSakaiKProcess design for efficient and controlled drug incorporation into polymeric micelle carrier systemsJ Control Release2002781–315516311772457
- YuJMLiYJQiuLYPolymeric nanoparticles of cholesterol modified glycol chitosan for doxorubicin delivery: preparation and in vitro and in vivo characterizationJ Pharm Pharmacol200961671371919505361
- StefanieWAlexanderKSvetlanaGKinetics of transport of doxorubicin bound to nanoparticles across the blood–brain barrierJ Control Release2011154110310721616104
- LodeJFichtnerIKreuterJInfluence of surface-modifying surfactants on the pharmacokinetic behavior of 14C-poly (methylmethacrylate) nanoparticles in experimental tumor modelsPharm Res200118111613161911758771
- AmbruosiAKhalanskyASYamamotoHBiodistribution of polysorbate 80-coated doxorubicin-loaded [14C]-poly(butyl cyanoacrylate) nanoparticles after intravenous administration to glioblastoma-bearing ratsJ Drug Target20061429710516608736
- BriggerIMorizetJLaudaniLNegative preclinical results with stealth nanospheres-encapsulated doxorubicin in an orthotopic murine brain tumor modelJ Control Release20041001294015491808
- BriggerIMorizetJAubertGPoly(ethylene glycol)-coated hexadecylcyanoacrylate nanospheres display a combined effect for brain tumor targetingJ Pharmacol Exp Ther2002303392893612438511
- CalvoPGouritinBChacunHLong-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain deliveryPharm Res20011881157116611587488